Morgan Stanley analyst Robert Davies raised the firm’s price target on Medacta Group to CHF 130 from CHF 125 and keeps an Equal Weight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MEDGF: